The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $61.58

Today's change0.00 0.00%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $61.58

Today's change0.00 0.00%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.

AbbVie Inc closed at (U.S.)$61.58.

Over the last five days, shares have lost 4.54% and are down 5.90% for the last year to date. This security has outperformed the S&P 500 by 13.41% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $61.58
  • High--
  • Low--
  • Bid / Ask(U.S.) $60.70 / (U.S.) $64.72
  • YTD % change-5.90%
  • Volume165
  • Average volume (10-day)14,314,092
  • Average volume (1-month)10,792,774
  • Average volume (3-month)9,316,834
  • 52-week range(U.S.) $52.06 to (U.S.) $71.60
  • Beta--
  • Trailing P/E48.17×
  • P/E 1 year forward14.50×
  • Forward PEG0.85×
  • Indicated annual dividend(U.S.) $2.04
  • Dividend yield3.31%
  • Trailing EPS(U.S.) $1.28
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.93%

Based on its net profit margin of 9.93%, AbbVie Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue5,4755,0405,4525,019
Total other revenue--------
Total revenue5,4755,0405,4525,019
Gross profit4,5594,0984,3333,955
Total cost of revenue9169421,1191,064
Total operating expense3,6233,3535,8674,059
Selling / general / administrative1,7031,3543,3411,595
Research & development981811879812
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)2324628315
Other operating expenses, total----500250
Operating income1,8521,687-415960
Interest income (expense), net non-operating-172-132-139-148
Gain (loss) on sale of assets--------
Other--------
Income before tax1,6781,396-1,037687
Income after tax1,3661,022-810506
Income tax, total312374-227181
Net income1,3661,022-810506
Total adjustments to net income--------
Net income before extra. items1,3661,022-810506
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,3661,022-810506
Inc. avail. to common incl. extra. items1,3661,022-810506
Diluted net income1,3661,022-810506
Dilution adjustment------0
Diluted weighted average shares1,6331,6081,5951,610
Diluted EPS excluding extraordinary itemsvalue per share0.840.64-0.510.31
Dividends per sharevalue per share0.510.510.420.42
Diluted normalized EPSvalue per share0.850.77-0.490.51